Dasatinib monotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia with pulmonary infection in induction remission: A case report and review of the literature

RATIONALE: There is currently no clinical standard for induction therapy in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+) ALL). Chemotherapy in combination with tyrosine kinase inhibitors (TKIs) recognized as the first line of therapy to induce remission in Ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cheng, Luo, Xiao-Qing, Zhang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160254/
https://www.ncbi.nlm.nih.gov/pubmed/30235679
http://dx.doi.org/10.1097/MD.0000000000012308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160254/
https://www.ncbi.nlm.nih.gov/pubmed/30235679
http://dx.doi.org/10.1097/MD.0000000000012308

Ejemplares similares